These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 7520633)
1. Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Yamamoto S; Nakata S; Shirakura R; Miyata M; Matsuda H; Stepkowski SM Transplant Proc; 1994 Aug; 26(4):2333-5. PubMed ID: 7520633 [No Abstract] [Full Text] [Related]
2. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients. Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059 [No Abstract] [Full Text] [Related]
3. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948 [No Abstract] [Full Text] [Related]
4. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476 [No Abstract] [Full Text] [Related]
5. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival. Cosenza CA; Cramer DV; Tuso PJ; Chapman FA; Wang HK; Makowka L J Heart Lung Transplant; 1994; 13(3):489-97. PubMed ID: 8061026 [TBL] [Abstract][Full Text] [Related]
6. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium. Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214 [TBL] [Abstract][Full Text] [Related]
7. Induction of tolerance in rat cardiac allograft model by intrathymic injection of donor bone marrow cells. Ito A; Ito T; Kamiike W; Nozaki S; Uchikoshi F; Tanaka T; Kuhara A; Moriguchi A; Miyata M; Nakata S Transplant Proc; 1995 Apr; 27(2):1607-8. PubMed ID: 7536974 [No Abstract] [Full Text] [Related]
8. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat. Knoop M; Cramer DV; Chapman FC; Makowka L Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719 [No Abstract] [Full Text] [Related]
9. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of acute rejection after skin or cardiac transplantation by administration of donor antigens in the rat. Shirouzu Y; Hikida S; Tanigawa H; Shirouzu K Surg Today; 2004; 34(4):341-8. PubMed ID: 15052450 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945 [No Abstract] [Full Text] [Related]
12. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft. Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227 [TBL] [Abstract][Full Text] [Related]
13. Effect of primary xenograft or allograft on the rejection of a subsequent allograft. Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376 [No Abstract] [Full Text] [Related]
14. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model. Murphy MP; Morris RE Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955 [No Abstract] [Full Text] [Related]
15. Effect of brequinar sodium on in vivo antibody production. Yasunaga C; Cramer DV; Cosenza CA; Tuso PJ; Chapman FA; Barnett M; Wu GD; Putnam BA; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):40-4. PubMed ID: 8516942 [No Abstract] [Full Text] [Related]
16. Analysis of mouse xenogeneic T-cell responses and the effect of FK 506 on these responses and on xeno-skin graft rejection. Fukuzawa M; Okada A Transplant Proc; 1994 Apr; 26(2):972-4. PubMed ID: 7513483 [No Abstract] [Full Text] [Related]
17. Beneficial effect of 15-deoxyspergualin on accelerated rejection in rat heart transplantation. Ueda H; Itoh S; Kusaka M; Isurugi K Transplant Proc; 1995 Feb; 27(1):420-2. PubMed ID: 7879046 [No Abstract] [Full Text] [Related]
18. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts. Chen H; Wu J; Xu D; Luo H; Daloze P Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790 [No Abstract] [Full Text] [Related]
19. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat. Chen H; Wu J; Xu D; Luo H; Daloze P Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454 [No Abstract] [Full Text] [Related]